Goldman, Sachs & Co analyst James Kelly trimmed his earnings estimate for Bristol-Myers Squibb and told investors to avoid the drugmaker's shares until management explains how it will compete with generic versions of its best-sellers.
What Kelly didn't do was cut his recommendation on stock in the maker of the cancer drug Taxol and the Glucophage diabetes medicines. He maintained Bristol-Myers, a Goldman Sachs banking client, as "market outperform" -- its version of a "buy."
Kelly's call represents an attempt to balance Goldman's investment-banking business with his own research, a common conflict that has undermined the authority of Wall Street analysis, some investors say.
"It may be they don't know what recommendation to use and the four-letter word `sell' doesn't exist anymore," said Donald Coxe, chairman and chief strategist of Harris Investment Management, which oversees US$16.5 billion and owns Bristol-Myers shares.
Goldman's Kelly said the company is likely to trim 2002 earnings projections at an investor meeting next Wednesday, and on Friday cut his own forecast by a nickel.
"We're telling investors to wait a few days because we want to see what Bristol says about the pipeline and whether that changes expectations," Kelly said.
Kelly said he maintained his rating on the stock because even assuming a worst-case scenario on 2002 earnings estimates the stock is still inexpensive.
Bristol-Myers shares have fallen 22 percent since Kelly initiated coverage on Nov. 29. During that time the Standard & Poor' S 500 Index fell 19 percent, and the Amex Pharmaceutical Index declined 13 percent.
The stock trades at about 21 times expected 2002 earnings, a 10 percent discount to the industry average, Kelly said. It slid 2.3 percent to US$53.04 on Friday.
Goldman Sachs's Kelly cut 2002 earnings per share estimates to US$2.55 from US$2.60.
The company is expected to earn US$2.62 a share, according to an average of analysts polled by Thomson Financial/First Call. Earnings-per-share projections could fall to as low as US$2.48, Kelly said.
Goldman, which took Bristol Myers public in 1969, has arranged the company's three bond sales since 1996 and advised on the sale of its Clairol hair-care unit to Procter & Gamble Co.
Kelly's concern revolves around the company's Glucophage line of diabetes medicines. The original top-selling drug may face competition from cheaper generics by year-end, and Bristol-Myers has been trying to switch patients to newer formulations of the drug for which there are no generic rivals.
As of mid-October, sales of the two new drugs represented about 38 percent of total Glucophage franchise sales, "a trend that needs to keep improving," Kelly said in a report.
Bristol-Myers's third-quarter profit rose less than 1 percent as generic drugs eroded sales of some the company's biggest- selling products, including Taxol and the anxiety medicine BuSpar.
"The story on Bristol-Myers is that earnings per share estimates have been coming down, and the share price reflects the below-trend growth,'' said Gene March, who runs Bristol-Myers shareholder Armada Equity Growth Fund for National City Investment Co. "It's a question of when you start to discount the stock properly."
Still, most analysts recommend investors buy more shares. There are currently 4 "strong buy" ratings, 11 "buy" ratings, and only 7 "hold" recommendations. There is also one "sell" recommendation.
Kelly said until the company sheds more light on the experimental products it intends to bring out next year it will be difficult to accurately assess the 2002 outlook.
"What we have is they suspect Bristol-Myers has something that may result in causing analysts to do downgrades," Coxe said. "I'm going to be intrigued about what they say next week. If they don't say something, I'll be even more perplexed."
The government is aiming to recruit 1,096 foreign English teachers and teaching assistants this year, the Ministry of Education said yesterday. The foreign teachers would work closely with elementary and junior-high instructors to create and teach courses, ministry official Tsai Yi-ching (蔡宜靜) said. Together, they would create an immersive language environment, helping to motivate students while enhancing the skills of local teachers, she said. The ministry has since 2021 been recruiting foreign teachers through the Taiwan Foreign English Teacher Program, which offers placement, salary, housing and other benefits to eligible foreign teachers. Two centers serving northern and southern Taiwan assist in recruiting and training
WIDE NET: Health officials said they are considering all possibilities, such as bongkrekic acid, while the city mayor said they have not ruled out the possibility of a malicious act of poisoning Two people who dined at a restaurant in Taipei’s Far Eastern Department Store Xinyi A13 last week have died, while four are in intensive care, the Taipei Department of Health said yesterday. All of the outlets of Malaysian vegetarian restaurant franchise Polam Kopitiam have been ordered to close pending an investigation after 11 people became ill due to suspected food poisoning, city officials told a news conference in Taipei. The first fatality, a 39-year-old man who ate at the restaurant on Friday last week, died of kidney failure two days later at the city’s Mackay Memorial Hospital. A 66-year-old man who dined
EYE ON STRAIT: The US spending bill ‘doubles security cooperation funding for Taiwan,’ while also seeking to counter the influence of China US President Joe Biden on Saturday signed into law a US$1.2 trillion spending package that includes US$300 million in foreign military financing to Taiwan, as well as funding for Taipei-Washington cooperative projects. The US Congress early on Saturday overwhelmingly passed the Further Consolidated Appropriations Act 2024 to avoid a partial shutdown and fund the government through September for a fiscal year that began six months ago. Under the package, the Defense Appropriations Act would provide a US$27 billion increase from the previous fiscal year to fund “critical national defense efforts, including countering the PRC [People’s Republic of China],” according to a summary
‘CARRIER KILLERS’: The Tuo Chiang-class corvettes’ stealth capability means they have a radar cross-section as small as the size of a fishing boat, an analyst said President Tsai Ing-wen (蔡英文) yesterday presided over a ceremony at Yilan County’s Suao Harbor (蘇澳港), where the navy took delivery of two indigenous Tuo Chiang-class corvettes. The corvettes, An Chiang (安江) and Wan Chiang (萬江), along with the introduction of the coast guard’s third and fourth 4,000-tonne cutters earlier this month, are a testament to Taiwan’s shipbuilding capability and signify the nation’s resolve to defend democracy and freedom, Tsai said. The vessels are also the last two of six Tuo Chiang-class corvettes ordered from Lungteh Shipbuilding Co (龍德造船) by the navy, Tsai said. The first Tuo Chiang-class vessel delivered was Ta Chiang (塔江)